0002035425-24-000001.txt : 20240828 0002035425-24-000001.hdr.sgml : 20240828 20240828065756 ACCESSION NUMBER: 0002035425-24-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b ITEM INFORMATION: Investment Company Act Section 3(c) ITEM INFORMATION: Section 3(c)(1) FILED AS OF DATE: 20240828 DATE AS OF CHANGE: 20240828 EFFECTIVENESS DATE: 20240828 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CaerusX Yatiri Bio SPV, a Series of Vauban Platform LP CENTRAL INDEX KEY: 0002035425 ORGANIZATION NAME: IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-522615 FILM NUMBER: 241251018 BUSINESS ADDRESS: STREET 1: 131 CONTINENTAL DRIVE STREET 2: SUITE 305 CITY: NEWARK STATE: DE ZIP: 19713 BUSINESS PHONE: 4342380920 MAIL ADDRESS: STREET 1: 131 CONTINENTAL DRIVE STREET 2: SUITE 305 CITY: NEWARK STATE: DE ZIP: 19713 D 1 primary_doc.xml X0708 D LIVE 0002035425 CaerusX Yatiri Bio SPV, a Series of Vauban Platform LP 131 CONTINENTAL DRIVE SUITE 305 NEWARK DE DELAWARE 19713 4342380920 DELAWARE None None Limited Partnership true 2024 - Vauban Capital GP LLC One World Trade Ctr New York NY NEW YORK 10007 Promoter General Partner of the Issuer - Vauban Advisers LLC One World Trade Ctr New York NY NEW YORK 10007 Promoter Investment Adviser of the Issuer Charly Kevers One World Trade Ctr New York NY NEW YORK 10007 Executive Officer EO of the General Partner Henry Shozen Ward One World Trade Ctr New York NY NEW YORK 10007 Executive Officer EO of the General Partner Pooled Investment Fund Venture Capital Fund false Decline to Disclose 06b 3C 3C.1 false 2024-08-26 false true false 1000 129974 129974 0 false 5 0 0 8000 One time payment to the GP for set up and administration false CaerusX Yatiri Bio SPV, a Series of Vauban Platform LP /s/ Kirk Carson Kirk Carson Authorized Signatory of the Issuer 2024-08-28